Status:

COMPLETED

A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia

Lead Sponsor:

Beijing InnoCare Pharma Tech Co., Ltd.

Conditions:

Waldenstrom's Macroglobulinemia Recurrent

Waldenstrom's Macroglobulinemia Refractory

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The phase II clinical study is to investigate the safety, tolerability, efficacy and pharmacokinetics of ICP-022. Safety, tolerability evaluation, and anti-tumor effects of ICP-022 in Chinese patient...

Eligibility Criteria

Inclusion

  • Key Inclusion criteria:
  • Clinical and histologically confirmed giant globulinemia Fahrenheit (WM Ii International Working Group Standards, IWWM-2, 2003) (Owen et al., 2003)
  • At least one treatment indication is met (7th WM International Working Group standards, IWWM-7) (Dimopoulos et al., 2014)
  • With the lowest serum IgM value \>2 times ULN as the efficacy evaluation index
  • ECOG physical strength score 0-2
  • Voluntary written informed consent prior to trial screening.
  • Key Exclusion Criteria:
  • Present or prior history of other malignant neoplasms, unless radical treatment has been performed and there is no evidence of recurrence or metastasis in the last 5 years
  • Amyloidosis and central nervous system (CNS) involvement caused by WM
  • Demonstrate disease transformation
  • Patients who had received autologous stem cell transplantation within the previous 6 months
  • A history of organ transplantation or allogeneic bone marrow transplantation
  • NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.

Exclusion

    Key Trial Info

    Start Date :

    August 10 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 9 2024

    Estimated Enrollment :

    47 Patients enrolled

    Trial Details

    Trial ID

    NCT04440059

    Start Date

    August 10 2019

    End Date

    January 9 2024

    Last Update

    April 18 2024

    Active Locations (16)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 4 (16 locations)

    1

    The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)

    Hefei, Anhui, China

    2

    Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, China, 100000

    3

    West China hospital of sichuan university

    Sichuan, Chengdu, China

    4

    Union Hospital affiliated to Fujian Medical University

    Fuzhou, Fujian, China